ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ADPT Adaptive Biotechnologies Corporation

3.515
-0.045 (-1.26%)
Last Updated: 10:34:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 236,938
Bid Price 3.51
Ask Price 3.52
News -
Day High 3.64

Low
2.28

52 Week Range

High
9.0799

Day Low 3.455
Company Name Stock Ticker Symbol Market Type
Adaptive Biotechnologies Corporation ADPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.045 -1.26% 3.515 10:34:17
Open Price Low Price High Price Close Price Prev Close
3.57 3.455 3.64 3.56
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,352 236,938 $ 3.54 $ 838,486 - 2.28 - 9.0799
Last Trade Time Type Quantity Stock Price Currency
10:34:17 100 $ 3.515 USD

Adaptive Biotechnologies Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
516.53M 145.09M - 170.28M -225.25M -1.55 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Adaptive Biotechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ADPT Message Board. Create One! See More Posts on ADPT Message Board See More Message Board Posts

Historical ADPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.993.7652.953.231,448,1710.52517.56%
1 Month2.593.7652.282.782,070,4650.92535.71%
3 Months3.964.3452.283.111,703,797-0.445-11.24%
6 Months3.835.492.283.721,613,576-0.315-8.22%
1 Year7.199.07992.284.791,426,411-3.68-51.11%
3 Years34.9543.39682.2810.881,171,718-31.44-89.94%
5 Years39.0171.252.2820.491,078,399-35.50-90.99%

Adaptive Biotechnologies Description

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Your Recent History

Delayed Upgrade Clock